Your browser doesn't support javascript.
loading
Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism.
Jayasena, Channa N; Anderson, Richard A; Llahana, Sofia; Barth, Julian H; MacKenzie, Finlay; Wilkes, Scott; Smith, Neil; Sooriakumaran, Prasanna; Minhas, Sukhbinder; Wu, Frederick C W; Tomlinson, Jeremy; Quinton, Richard.
Afiliação
  • Jayasena CN; Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, UK.
  • Anderson RA; MRC Centre for Reproductive Health, University of Edinburgh, UK.
  • Llahana S; School of Health Sciences, City, University of London, London & Department of Endocrinology & Diabetes, University College London Hospitals (UCLH) NHS Foundation Trust, London, UK.
  • Barth JH; Specialist Laboratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • MacKenzie F; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Wilkes S; School of Medicine, University of Sunderland, Sunderland, UK.
  • Smith N; Patient member.
  • Sooriakumaran P; Department of Uro-oncology, UCLH NHS Foundation Trust, London & Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Minhas S; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Wu FCW; Division of Endocrinology, Diabetes & Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Tomlinson J; Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, UK.
  • Quinton R; Department of Endocrinology, Diabetes & Metabolism, Newcastle-upon-Tyne Hospitals NHS Foundation Trust & Translational & Clinical Research Institute, University of Newcastle-upon-Tyne, UK.
Clin Endocrinol (Oxf) ; 96(2): 200-219, 2022 02.
Article em En | MEDLINE | ID: mdl-34811785
Male hypogonadism (MH) is a common endocrine disorder. However, uncertainties and variations in its diagnosis and management exist. There are several current guidelines on testosterone replacement therapy that have been driven predominantly by single disciplines. The Society for Endocrinology commissioned this new guideline to provide all care providers with a multidisciplinary approach to treating patients with MH. This guideline has been compiled using expertise from endocrine (medical and nursing), primary care, clinical biochemistry, urology and reproductive medicine practices. These guidelines also provide a patient perspective to help clinicians best manage MH.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças do Sistema Endócrino / Endocrinologia / Hipogonadismo Tipo de estudo: Guideline Limite: Humans / Male Idioma: En Revista: Clin Endocrinol (Oxf) Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doenças do Sistema Endócrino / Endocrinologia / Hipogonadismo Tipo de estudo: Guideline Limite: Humans / Male Idioma: En Revista: Clin Endocrinol (Oxf) Ano de publicação: 2022 Tipo de documento: Article